Molecular Partners(MOLN.US)

Event Tracking

Dec7

Molecular Partners AG Announces Positive Trial Results of MP0533 for AML at ASH Meeting

12:00

Nov12

Molecular Partners AG Submits IND Application for Small Cell Lung Cancer Drug

06:01

Nov3

Molecular Partners AG Releases Data on MP0533 Clinical Trial

06:00

Oct31

Molecular Partners released FY2025 Q3 earnings on October 30 (EST), actual EPS USD -0.3968 (forecast USD -0.4639)

03:00

Molecular Partners released FY2025 9 Months Earnings on October 30, 2025 (EST) with actual revenue of USD 0 and EPS of USD -1.5948

03:00

Oct30

Molecular Partners AG Reports Third Quarter Progress in Cancer Therapy and Appoints New Chief Science Officer

20:14

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -14.84 M, EPS -0.3968

Aug25

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -25.5 M, EPS -0.682

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -19.02 M, EPS -0.5158

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change